Evolocumab Added to Statin Is Associated With Intracranial Atherosclerotic Plaque Regression Compared With Statin Alone

Evolocumab Added to Statin Is Associated With Intracranial Atherosclerotic Plaque Regression Compared With Statin Alone

Background We aimed to investigate the effects of evolocumab, a proprotein convertase subtilisin/kexin type‐9 inhibitor for intensive lipid‐lowering, on intracranial atherosclerotic stenosis. Methods From a prospectively established high‐resolution magnetic resonance imaging database, consecutive pa...

Full description

Saved in:
Bibliographic Details
Main Authors: Xinzhi Hu, Yiyang Liu, Weizhuang Yuan, Zongmuyu Zhang, Shun Li, Anqi Cheng, Qiuyu Yu, Haoyao Guo, Yinxi Zou, Mingli Li, Caiyan Liu, Yan Xu, Weihai Xu
Format: Article
Language:English
Published: Wiley 2025-08-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
high‐resolution MRI
intracranial atherosclerotic stenosis
PCSK9 inhibitor
plaque regression
statin
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.124.041251
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.124.041251

Similar Items